Page last updated: 2024-10-30

metformin and Astrocytosis

metformin has been researched along with Astrocytosis in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Lafora disease is a fatal form of progressive myoclonic epilepsy caused by mutations in the EPM2A or NHLRC1/EPM2B genes that usually appears during adolescence."1.91Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease. ( Burgos, DF; Giráldez, BG; González-Fernández, J; Iglesias-Cabeza, N; Machío-Castello, M; Sánchez, MP; Sánchez-Martín, G; Serratosa, JM, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Burgos, DF1
Machío-Castello, M1
Iglesias-Cabeza, N1
Giráldez, BG1
González-Fernández, J1
Sánchez-Martín, G1
Sánchez, MP2
Serratosa, JM2
Grissi, M1
Boudot, C1
Assem, M1
Candellier, A1
Lando, M1
Poirot-Leclercq, S1
Boullier, A1
Bennis, Y1
Lenglet, G1
Avondo, C1
Lalau, JD1
Choukroun, G1
Massy, ZA1
Kamel, S1
Chillon, JM1
Hénaut, L1
Berthier, A1
Payá, M1
García-Cabrero, AM1
Ballester, MI1
Heredia, M1
Sanz, P1

Other Studies

3 other studies available for metformin and Astrocytosis

ArticleYear
Early Treatment with Metformin Improves Neurological Outcomes in Lafora Disease.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2023, Volume: 20, Issue:1

    Topics: Animals; Follow-Up Studies; Gliosis; Lafora Disease; Metformin; Mice; Ubiquitin-Protein Ligases

2023
Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease.
    Scientific reports, 2021, 04-02, Volume: 11, Issue:1

    Topics: Adenylate Kinase; Animals; Apoptosis; Body Weight; Brain Infarction; Enzyme Activation; Female; Gene

2021
Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.
    Molecular neurobiology, 2016, Volume: 53, Issue:2

    Topics: Animals; Brain; Disease Models, Animal; Fluorescent Antibody Technique; Gliosis; Glucans; Hippocampu

2016